HK:6622 Stock Latest News
Company AnnouncementsZhaoke Ophthalmology Wins Australian GMP Nod for Guangzhou Plant5d ago6622
Company AnnouncementsZhaoke Ophthalmology’s Presbyopia Drug YUVEZZI™ Clears Phase II Milestone in China1M ago6622
Company AnnouncementsZhaoke Ophthalmology Posts Higher Revenue but Sustains Heavy R&D-Driven Losses in First Half 20262M ago6622
Company AnnouncementsZhaoke Ophthalmology Sets Board Meeting to Approve Interim Results2M ago6622
Company AnnouncementsZhaoke Ophthalmology Taps Pharmentum for China Rollout of Allergy Eye Drug2M ago6622
Company AnnouncementsZhaoke Ophthalmology Wins Macau Approval for Presbyopia Drug YUVEZZI3M ago6622Company AnnouncementsZhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK0023M ago6622
Company AnnouncementsZhaoke Ophthalmology Wins Boao Approval for First Innovative Presbyopia Drug in China3M ago6622
Company AnnouncementsZhaoke Ophthalmology’s Myopia Drug NVK002 Accepted for Australian TGA Evaluation4M ago6622
Company AnnouncementsZhaoke Ophthalmology Launches HK$100 Million Share Buy-Back Plan4M ago6622
Company AnnouncementsZhaoke Ophthalmology Strikes Indonesia Distribution Deal for Dry Eye Gel4M ago6622- Company AnnouncementsZhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM5M ago6622
Company AnnouncementsZhaoke Ophthalmology Renews Related-Party CMO Deal for Eyprotor6M ago6622Company AnnouncementsZhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates6M ago6622
Company AnnouncementsZhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules6M ago6622
- Company AnnouncementsZhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 20257M ago6622
- Company AnnouncementsZhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results7M ago6622
Company AnnouncementsZhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam9M ago6622
Company AnnouncementsZhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA9M ago6622Company AnnouncementsZhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry10M ago6622
Company AnnouncementsZhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments11M ago6622
